Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EORTC 22921: Pre-op RT +/- Chemo in Rectal Cancer
NCT00002523Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 1993
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of fluorouracil in rectal cancer (4 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Overall Survival at 10 years. Started Apr 1993; status: completed.
02
Drugs
fluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00002523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002523.